Risk Based Strategies for Extractables and Leachables in Different Dosage Forms Risk Based Strategies for Extractables and Leachables in Different Dosage Forms The pharmaceutical and biotechnology industries are increasingly focused on ensuring the safety and efficacy of drug products. A critical aspect of drug formulation and packaging is the assessment of extractables and leachables (E&L), which can impact patient safety and product reliability. This article outlines the risk-based strategies for managing extractables and leachables in various dosage forms while aligning with regulatory expectations set by the FDA, EMA, and MHRA. Understanding Extractables and Leachables Extractables refer to the chemicals that…

Regulatory expectations for E and L data in NDAs, BLAs and inhalation products Regulatory Expectations for E and L Data in NDAs, BLAs and Inhalation Products Introduction to Extractables and Leachables in Pharmaceutical Packaging Extractables and Leachables (E and L) studies are crucial in assessing the safety and compatibility of packaging systems used for pharmaceuticals, biologics, and inhalation products. The U.S. Food and Drug Administration (FDA) and other global regulatory authorities, such as the European Medicines Agency (EMA) and the Medicines and Healthcare products Regulatory Agency (MHRA), provide guidelines that emphasize the importance of E and L characterization. This article…

How to design an E and L study for primary packaging and container closures How to design an E and L study for primary packaging and container closures As the pharmaceutical industry increasingly relies on complex and innovative packaging systems, it becomes essential to qualify these systems properly to ensure product safety and efficacy. One critical component in this qualification is the assessment of extractables and leachables (E and L) from primary packaging and container closures. This article provides a comprehensive overview of how to design an E and L study in alignment with regulatory expectations from the FDA, EMA,…

Extractables and Leachables Programs for Pharmaceutical Packaging Systems Extractables and Leachables Programs for Pharmaceutical Packaging Systems The importance of understanding extractables and leachables (E and L) in pharmaceutical packaging systems cannot be overstated. With increasing regulatory scrutiny and the relentless push for patient safety, it is vital for professionals in the pharmaceutical, clinical operations, regulatory affairs, and medical affairs fields to have an in-depth knowledge of E and L testing and its implications for packaging qualification. This article serves as a comprehensive guide to extractables and leachables programs, paying close attention to the expectations set forth by the FDA as…

How to align packaging E and L with ICH, PQRI and FDA guidances Aligning Packaging Extractables and Leachables with ICH, PQRI, and FDA Guidelines In the pharmaceutical industry, ensuring the safety and efficacy of drug products is a paramount concern that dictates numerous regulatory practices. One critical aspect of this assurance involves the assessment of extractables and leachables (E and L) arising from packaging systems. Regulations established by the US Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the Medicines and Healthcare products Regulatory Agency (MHRA) demand meticulous compliance with packaging safety assessments. This article serves as…

Extractables and Leachables for Prefilled Syringes, Cartridges and DDCs Extractables and Leachables for Prefilled Syringes, Cartridges and DDCs The pharmaceutical industry faces continuous pressure to ensure the safety and efficacy of drugs throughout their lifecycle. A critical component in this regard is the assessment of extractables and leachables (E and L) from packaging systems such as prefilled syringes, cartridges, and drug delivery devices (DDCs). Understanding the regulatory framework and best practices for conducting E and L safety assessments is vital for compliance with FDA, EMA, and MHRA expectations. This article serves as a comprehensive guide for professionals engaged in regulatory…

E and L considerations for elastomers, adhesives, coatings and inks E and L considerations for elastomers, adhesives, coatings and inks The pharmaceutical packaging landscape is evolving, highlighting the critical importance of managing extractables and leachables (E&L) in the context of elastomers, adhesives, coatings, and inks. Regulatory authorities, including the US FDA, EMA, and MHRA, outline explicit expectations for E&L safety assessments within their frameworks, necessitating a comprehensive understanding of the associated risks and methodologies. This article serves as a detailed explainer manual for packaging professionals and regulatory experts working in pharmaceutical settings. Understanding Extractables and Leachables Extractables and leachables refer…

Toxicological Assessment and Safety Qualification of Identified Leachables Toxicological Assessment and Safety Qualification of Identified Leachables The integration of effective safety assessments for extractables and leachables (E&L) within the pharmaceutical packaging ecosystem serves as a critical component in ensuring the safety and efficacy of pharmaceutical products. This article provides an in-depth exploration of the toxicological assessments required for identified leachables, highlighting the FDA’s expectations and international regulatory alignment, particularly focusing on the frameworks set forth by the EMA and MHRA. Understanding Extractables and Leachables in Pharmaceutical Packaging Extractables and leachables refer to substances that can migrate from packaging materials into…

Selecting Analytical Methods for Volatile, Semi-Volatile, and Non-Volatile Leachables Selecting Analytical Methods for Volatile, Semi-Volatile, and Non-Volatile Leachables The management of extractables and leachables (E&L) in pharmaceutical packaging systems is critical for ensuring product safety and compliance with regulatory expectations established by bodies such as the FDA, EMA, and MHRA. Such considerations are especially pertinent due to the potential interaction between packaging materials and pharmaceutical formulations. Understanding which analytical methods to apply is essential for both product integrity and regulatory compliance. This article systematically discusses the selection of appropriate analytical methods for volatile, semi-volatile, and non-volatile leachables, focusing on E&L…

Case Studies of Leachables Issues Leading to Recalls and Safety Concerns Case Studies of Leachables Issues Leading to Recalls and Safety Concerns Leachables, substances that migrate from packaging into pharmaceutical products, have become a significant focus in regulatory affairs and quality assurance practices. Understanding the implications of extractables and leachables (E&L) is paramount for ensuring patient safety and regulatory compliance, particularly in the realm of FDA expectations. This article will explore notable case studies highlighting leachables issues that resulted in product recalls and safety concerns, analyzing the implications for regulatory practices in the US, UK, and EU. Understanding Extractables and…